Vascular tone control in humans:: Insights from studies in Bartter's/Gitelman's syndromes

被引:62
作者
Calò, LA [1 ]
机构
[1] Univ Padua, Dept Clin & Expt Med, Clin Med 4, I-35128 Padua, Italy
关键词
hypertension; angiotensin II signaling; Rho kinase;
D O I
10.1038/sj.ki.5000253
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Studies in patients with Bartter's and Gitelman's syndromes performed in the last 10 years have provided important insights into the mechanistic details of relevant pathways of angiotensin II signaling and vascular tone regulation, therefore making these syndromes a good human model to gain insight into the mechanisms responsible for maintaining/controlling vascular tone. Extensive studies of patients with Bartter's/Gitelman's syndromes have, in fact, shown biochemical abnormalities of angiotensin II short- and long-term cell signaling, which depict a mirror image of those found in hypertension. The information obtained from the study of this human model of altered vascular tone regulation show that it can be used to gather more general data and/or confirm mechanistic details of the cellular and biochemical events involved in the pathophysiology of vascular tone control and to shed light on the multiplicity of the angiotensin II signaling-related mechanisms responsible for the pathophysiology of hypertension and its long-term complication such as cardiovascular remodeling and atherogenesis.
引用
收藏
页码:963 / 966
页数:4
相关论文
共 49 条
[21]   RESTING AND STIMULATED CYTOSOLIC FREE CALCIUM LEVELS IN NEUTROPHILS FROM PATIENTS WITH BARTTERS-SYNDROME [J].
DIVIRGILIO, F ;
CALO, L ;
CANTARO, S ;
FAVARO, S ;
PICCOLI, A ;
BORSATTI, A .
CLINICAL SCIENCE, 1987, 72 (04) :483-488
[22]   Tissue angiotensin and pathobiology of vascular disease - A unifying hypothesis [J].
Dzau, VJ .
HYPERTENSION, 2001, 37 (04) :1047-1052
[23]   Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells [J].
Fukata, Y ;
Amano, M ;
Kaibuchi, K .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (01) :32-39
[24]   NAD(P)H oxidase - Role in cardiovascular biology and disease [J].
Griendling, KK ;
Sorescu, D ;
Ushio-Fukai, M .
CIRCULATION RESEARCH, 2000, 86 (05) :494-501
[25]   Oxidative stress and cardiovascular injury - Part II: Animal and human studies [J].
Griendling, KK ;
FitzGerald, GA .
CIRCULATION, 2003, 108 (17) :2034-2040
[26]   Emerging roles for RGS proteins in cell signalling [J].
Hepler, JR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (09) :376-382
[27]   Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice [J].
Heximer, SP ;
Knutsen, RH ;
Sun, XG ;
Kaltenbronn, KM ;
Rhee, MH ;
Peng, N ;
Oliveira-Dos-Santos, A ;
Penninger, JM ;
Muslin, AJ ;
Steinberg, TH ;
Wyss, JM ;
Mecham, RP ;
Blumer, KJ .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (04) :445-452
[28]   Gene regulation of heme oxygenase-1 as a therapeutic target [J].
Immenschuh, S ;
Ramadori, G .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1121-1128
[29]   Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells [J].
Li, YA ;
Hashim, S ;
Anand-Srivastava, MB .
CARDIOVASCULAR RESEARCH, 2005, 66 (03) :503-511
[30]   The heme oxygenase system: A regulator of second messenger gases [J].
Maines, MD .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :517-554